Tag: kamp

kamp

DTC Advertising

McCaskill Proposal to End Tax Deduction for DTC Marketing Re-emerges

McCaskill Proposal to End Tax Deduction for DTC Marketing Re-emerges

March 1, 2018 – After filing an amendment to the tax bill last year to eliminate the tax deduction for drug marketing expenses — which did not move forward — Sen. Claire McCaskill (D-Mo.) today announced a bill that would amend the tax code to “deny the deduction for advertising and promotional expenses for prescription […]

Read more

DTC Advertising

Ad Agency on Hook for $2 Million for Deceptive Weight-loss Promotions

Ad Agency on Hook for $2 Million for Deceptive Weight-loss Promotions

Feb. 12, 2018 – The Federal Trade Commission (FTC) and the Maine Attorney General announced a $2 million settlement Feb. 6 against Marketing Architects Inc., an ad agency that “created and disseminated allegedly deceptive radio ads for weight-loss products marketed by its client, Direct Alternatives,” according to the FTC. Marketing Architects also provided interactive voice […]

Read more

Washington Focus

The Marketing Implications of Tax Reform

The Marketing Implications of Tax Reform

By John Kamp, Coalition for Healthcare Communication Executive Director May 11, 2017 – Although no one seems to like the new Trump/Ryan healthcare bill, House staffers now (finally) are preparing for the next big Republican effort – overhauling the tax system for both individuals and corporations. Like healthcare, everyone seems to agree that an overhaul […]

Read more

CHC News

Coalition Rising Leaders Conference Helps Medical Marketers Answer Pressing Questions

Coalition Rising Leaders Conference Helps Medical Marketers Answer Pressing Questions

April 11, 2017 – There is no doubt that the Trump administration is likely to change health policy in the near future, but the questions that remain to be answered are exactly what those changes will be and how they will affect healthcare communication. For predictions and insight from an expert panel of FDA and […]

Read more

Washington Focus

Kamp: Buckle Up for a Bumpy Ride with Trump

Kamp: Buckle Up for a Bumpy Ride with Trump

Coalition Commentary by Executive Director John Kamp Feb. 6, 2017 — Fasten your seatbelts and put your tray tables in their upright and locked position as you watch the Trump administration land on our industry. At a recent White House meeting with PhRMA and industry CEOs,  Trump made sure the cameras were rolling as he […]

Read more

Washington Focus

Kamp: Moving forward after the election

Kamp: Moving forward after the election

Nov. 11, 2016 – Post-election report from Coalition for Healthcare Communication Executive Director John Kamp: The pollsters and pundits sure got it wrong. As they look back to correct their errors, the new reality of a Trump Administration and a Republican-controlled House and Senate provides some clues to the future of our industry. As our […]

Read more

CHC News

Report from the Coalition Executive Director

Report from the Coalition Executive Director

Nov. 8, 2016 – When the votes are counted, expect many discussions on what will happen next. One thing is certain – there is change ahead. To get the real skinny on what will happen to medical marketing, attend the Coalition for Healthcare Communication post-election meeting next Wednesday and Thursday in Washington. Speakers from throughout […]

Read more

Off-label Promotion

Kamp to Urge FDA to Provide Clear Guidance on Off-label Communication at November Hearing

Kamp to Urge FDA to Provide Clear Guidance on Off-label Communication at November Hearing

Oct. 31, 2016 – In testimony at the upcoming off-label hearing at the FDA, Coalition for Healthcare Communication Executive Director John Kamp will emphasize that FDA must quickly develop rules that are clear and consistent with the First and Fifth Amendments. The FDA today released the draft agenda for its two-day meeting on manufacturer communication […]

Read more

Kamp: Pharma Needs to Step up to Stem Opioid Abuse

Oct. 17, 2016 – In a recent guest commentary in PM360, Coalition for Healthcare Communication Executive Director John Kamp praised Pfizer for its opioid agreement with the City of Chicago and called on the pharmaceuticals industry to engage now in the fight to help stem the tide of opioid addiction. In the PM360 piece, “In […]

Read more

Regulatory/FDA

CMS Clarifies Sunshine Act CME Exclusion

CMS Clarifies Sunshine Act CME Exclusion

Oct. 6, 2016 – The Centers for Medicare & Medicaid Services (CMS) recently clarified in a revised FAQ that manufacturers that provide a payment or transfer of value to support continuing medical education (CME) but do not specify that the CME provider should offer payment to a specific physician speaker or faculty member would not […]

Read more